Stop Digging for Data: Uncover Productivity Issues and Opportunities in Minutes

 

Sterile Processing Departments (SPDs), as with all other industries in healthcare, are struggling with supply chain concerns, a lack of steady commitment from staff, and a workforce shortage. Additionally, SPDs have long dealt with issues in staffing shortages, which even extends to how facilities maximize their spaces. Seamus Johnson, Senior Director of Application Development at Censis Technologies, and Barry Phetteplace, Chief Technology Officer at Censis Technologies, spoke with Tyler Kern about these issues and how powerful data analytics tools like CensisAI2 Productivity can help combat these challenges. 

Understanding resource utilization and where the gaps lie is fundamental to creating the efficiencies required to get the job done when workers are in short supply. 

“Until you’ve delved into that data and really understand, a lot of times it’s guesswork,” Phetteplace said. “If you’re a small SPD where you only have a few techs, maybe it’s a little easier, but if you’re a large facility or a large IDN with multiple facilities, it becomes that much more difficult.” 

Johnson said there are several levels of data that perioperative and sterile processing leaders want, and need visibility over their operative needs. “At the high level, what’s important is being able to see everything your department’s doing, seeing what your throughput is in terms of how many trays you’re able to process for the OR. That’s your capacity to support the cases and patients.” 

Having data is one thing; accessing it and making sense of it is another. Creating cumbersome pivot tables can take hours to get the data into usable shape. It isn’t typically something a person running a sterile processing department wants to spend their valuable time doing. Phetteplace said Censis understands these challenges. Censis designed CensisAI2 Productivity to provide a faster way to analyze data. “We want to understand if we’re winning or losing. That was the mantra we had going into this, understanding the concept of productivity. It shouldn’t take me fifteen minutes to dig through tab after tab and look at complicated charts and graphs to understand if I’m winning or losing.” 

Interested in learning more about Censis Technologies’ surgical asset management platform? Visit Censis.com.

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More